Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)
Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of fingolimod 0.5mg versus placebo in patients with
suspected acute demyelinating optic neuritis (ADON) receiving standard steroid treatment